Last week, CBSA co-hosted an educational event for legislators and other stakeholders in partnership with PhRMA and Colorado Politics. The event featured a panel discussion that addressed the drivers of costs in Colorado’s healthcare system, specifically focused on costs related to the federal 340B Drug Pricing Program, health system consolidation, and vertical integration in the system. The conversation referenced the latest data and considered solutions that could improve access for vulnerable Colorado communities to prescribed medicines purchased through hospitals and their contract pharmacies – and pathways to saving employer, patient, and systemic state costs.
An article from Colorado Politics explains the issues and data highlighted by the panelists and how “a program developed in the 1990s allowing healthcare organizations to purchase discounted outpatient drugs to help low-income patients has grown into a system of abuse and misuse without…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
